A randomized trial found that the use of UV-C machines can cut transmission of four major superbugs by a cumulative 30 percent, according to an article on the Infection Control Today website.
The study was led by Duke Health and published in The Lancet. Its results are specific to patients who stay overnight in a room where someone with a known positive culture or infection of a drug-resistant organism had previously been treated.
The researchers focused on: MRSA, vancomycin-resistant enterococci (VRE), C. difficile and Acinetobacter.
The facilities studied used a portable machine called the Tru-D SmartUV-C to disinfect rooms where patients with the target bacteria had been staying.
Creating Healthcare Campus Master Plans That Allow Movement and Respite
Aspirus Health Celebrates Opening of Chippewa Falls Hospital and Clinic
AdventHealth to Open Aurora Highlands Medical Campus
The Future of Healthcare Facility Construction Projects
Arnprior Regional Health Upgrades Building Controls to Improve IEQ